Clinical trial of docetaxel and cisplatin combined with 5-fluorouracil in the treatment of patients with nasopharyngeal carcinoma
10.13699/j.cnki.1001-6821.2017.22.009
- VernacularTitle:多西他赛和顺铂联合氟尿嘧啶治疗鼻咽癌患者的临床研究
- Author:
Peng WAN
1
;
Zu-Guo YUAN
;
Hui YANG
;
Yu ZHANG
;
Ji-Peng LI
Author Information
1. 宁波市鄞州人民医院肿瘤放化疗中心
- Keywords:
nasopharyngeal carcinoma;
docetaxel;
cisplatin;
5-fluorouracil;
radiotherapy
- From:
The Chinese Journal of Clinical Pharmacology
2017;33(22):2243-2246
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the short-term efficacy,survival rate of docetaxel + cisplatin + 5-fluorouracil (DCF) and docetaxel + cisplatin (DP) combined with chemo-radiotherapy regimens in patients with stage Ⅲ-ⅣB nasopharyngeal carcinoma.Methods A total of 230 patients with Ⅲ-Ⅳ B nasopharyngeal carcinoma in our hospital were randomly divided into treatment group and control group,115 cases in each group.Control group were received concurrent radiotherapy and chemotherapy for 3 courses.On 1-3 d,patients were treated with intravenous infusion docetaxel (DTX) 100 mg · m-2,on second day intravenous infusion cisplatin (DDP) 75 mg · m-2,and 21 d a course.Treatment group were received 2 courses of radiotherapy and chemotherapy.On the first day,patients were given intravenous infusion docetaxel 75 mg · m-2,cisplatin 75 mg · m-2,1-5 d intravenous infusion 5-fluorouracil (5-FU) 750 mg · m-2,and 21 d a course.During the treatment,the blood was examined every week,heart,lung and kidney function was reexamined every 2 weeks.The short-term efficacy,nasopharyngeal lesions and neck metastasis,lymph node regression,adverse drug reactions and survival rate were observed in two groups.Results After treatment,the tumor target volume in treatment group was (36.44 ± 4.29) cm3,the reduction rate was 25.63％,had no significant difference with those in control group,which were (36.36 ±5.10)cm3,25.92％ (P ＞0.05).The response rates of control group and treatment group were 99.13％ and 100.00％ (P ＞ 0.05).Patients in grade Ⅲ and Ⅳ stratified analysis showed that the overall survival(OS),metastasis free survival (MFS),tumor recurrent free survival (TRFS) in grade Ⅲ had significant difference in two groups (P ＜0.05).The OS,MFS,disease free survival (DFS) of grade Ⅳ in two groups all had significant difference (P ＜ 0.05).The incidence of leucopenia,hemoglobin decreased,thrombocytopenia,nausea,vomiting and mucositis in two groups had significant difference (P ＜ 0.05).Conclusion Compared with DP and concurrent radiotherapy,DCF chemotherapy and concurrent radiotherapy can prolong the overall survival rate of patients with locally advanced nasopharyngeal carcinoma,but increase the incidence of adverse drug reactions.There is no significant difference between the two groups in short-term clinical effect.
